Properties (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_the_Bausch_Health_Companies
|
| gptkbp:advertising |
Focus on niche markets
|
| gptkbp:businessModel |
Focus on business development
Develop_and_commercialize_innovative_therapies |
| gptkbp:CEO |
V._Paul_S._S._D._McGinnis
|
| gptkbp:clinicalTrials |
Phase 3 trials
Phase 1 trials Phase 2 trials Conducts clinical studies Generates clinical data Innovative therapies for eye diseases |
| gptkbp:collaborations |
Partnerships with research institutions
|
| gptkbp:community_engagement |
Involved in community outreach
|
| gptkbp:competitors |
Conducts market research
|
| gptkbp:employeeCount |
Over 200
|
| gptkbp:feedback |
Focus on improving clinical outcomes
|
| gptkbp:financialPerformance |
Revenue growth
|
| gptkbp:focus |
Ophthalmology
|
| gptkbp:founded |
2008
|
| gptkbp:founder |
gptkb:D._Michael_McGinnis
|
| gptkbp:future_plans |
Engages in strategic planning
|
| gptkbp:headquarters |
gptkb:Durham,_North_Carolina
|
| gptkbp:healthcare |
Provides patient education resources
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aerie Pharmaceuticals
|
| gptkbp:investmentFocus |
Institutional investors
Venture capital funding Maintains investor relations |
| gptkbp:leadership |
Experienced management team
|
| gptkbp:market |
Approximately $1 billion
Strong market presence in ophthalmology. |
| gptkbp:partnerships |
Collaborations with other companies
Collaboration_with_the_University_of_California,_San_Diego Collaboration_with_the_University_of_North_Carolina |
| gptkbp:patentCitation |
Holds multiple patents
|
| gptkbp:productLine |
Diverse product pipeline
|
| gptkbp:products |
gptkb:Netarsudil
gptkb:Rhopressa gptkb:Roclatan Aerie's_investigational_drugs Aerie's_pipeline |
| gptkbp:publications |
Contributes to scientific literature
|
| gptkbp:regulatoryCompliance |
Adheres to regulatory standards
FDA_approval_for_Rhopressa FDA_approval_for_Roclatan |
| gptkbp:research |
gptkb:Dr._David_A._Stump
|
| gptkbp:research_areas |
Ocular hypertension
Open-angle glaucoma |
| gptkbp:research_focus |
Intraocular pressure
|
| gptkbp:researchAndDevelopment |
Significant investment in R&D
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:supplyChain |
Robust supply chain management
|
| gptkbp:targetMarket |
Successful product launches
Glaucoma_patients |
| gptkbp:website |
www.aeriepharma.com
|